is the fda stopping compounded semaglutide has strictly clarified that with the national supply of GLP-1 medications stabilizing, compounders can no longer produce "essentially copies" of FDA-approved drugs. Enforcement discretion periods for drugs like and Compounded "semaglutide" is not FDA-approved

Drugmaker Eli Lilly, which makes Zepbound, is also testing its obesity medications in children ages six and up

10.1016/S2665-9913(23)00163-7 51 Gladkova

In a study of people who switched from semaglutide to tirzepatide, the most common side effects were nausea, constipation, and diarrhea

These autoantibodies form immune complexes that deposit in various tissues and organs, leading to organ damage

GLP-1 drugs have been around for more than a decade to help people manage type 2 diabetes, but the ones developed in recent yearsOzempic, Wegovy, Mounjaro, and Zepboundhave exploded in popularity after becoming the worst-kept celebrity weight-loss secret

It is backed by ISO 17025-accredited third-party testing and NSF-certified manufacturing